Annual Continuing Review
The Annual Continuing Review process begins one year after the initial protocol was approved by the IBC. The review confirms all IBC work is being performed at previously approved containment levels, that personnel and training are up to date, and that biosafety cabinet certifications and funding are current.
Once approved, your protocol’s expiration date is extended for another year. This process is repeated the second year. After three years, we must completely reevaluate the protocol.
You will receive notification if there are stipulations to your Annual Continuing Review. Approval notices are sent via automated email and your Continuing Review’s status will appear as "APPROVED".
Annual Continuing Review or Three-Year Renewal
The three-year renewal is the process of submitting a new application for a full review of the ongoing study.
If your protocol has been active for three years, complete a three-year renewal application instead of a continuing review.
Failure to complete the correct application will delay review and might result in a lapse of approval.
When to Submit an Annual Continuing Review Form
We will send notices to the principal investigator, co-investigator(s) and administrative contact of a protocol 30 days, 15 days, and 1 day before its expiration. Please note, in rare cases, some investigators have not received these courtesy emails due to some bugs in the eProtocol system. Please help us by keeping a reminder notification to yourself in your calendar.
When you receive the Annual Continuing Review notice, create, complete, and submit the Continuing Review form. Job Aid: IBC Annual Continuing Review
You may also request closure of your protocol during the Annual Continuing Review process if experimental work is complete or discontinued.
I just received an expiration note for the Annual Continuing Review of my protocol, but the expiration date I see for my protocol is a few years out. Why did I receive the renewal note?
The eProtocol system only lists the final three-year expiration date for your protocol, not the annual expiration date.
Failure to Complete a Required Continuing Review
If you allow the protocol to expire, we will suspend the protocol and notify you via email.
While suspended, all activities involving r/sNA molecules, infectious agents, and biological toxins must cease until the protocol has been reactivated.
Contact us at email@example.com or 612-626-2161 to inquire about reactivating a "suspended" study.